Diabetes, Obesity, and COVID-19

October 15, 2020

Available as of November 10, 2020

As countries focus on preventing deaths linked to COVID, unintentionally, they have been ignoring chronic complex comorbid conditions like diabetes and obesity. We now know that these comorbidities contribute significantly to COVID deaths. Key to reducing COVID deaths is not to ignore chronic complex comorbid conditions. People should continue seeking care for their comorbidities and work on managing them effectively. 

Learning Objectives:

  • Understand risk factors associated with COVID deaths
  • Understand how diabetes and obesity contribute to COVID severity
  • Understand ways to manage diabetes and obesity


Ashley Hodes

Santosh Agarwal
Director, Healthcare Economics, Policy, and Reimbursement, Surgical Innovations, Medtronic

Santosh is currently the director for healthcare economics, health policy and reimbursement with Medtronic. He also serves as the Government Affairs liaison for Medtronic’s Medical Surgical business. Santosh has been a part of a team to understand the epidemiological trends, evolving data and evidence and implications of COVID-19 pandemic. Specifically, he has been studying at-risk populations for COVID-19, impact of COVID on non-COVID conditions. He has been training healthcare professionals in countries like US, Bangladesh, Myanmar on COVID related aspects like surveillance, infection prevention and control. He has been with Medtronic for 11 years and spent a lot of time on data analytics and value communication. Santosh has degrees in Pharmacy and Business Administration. He is passionate about access to care, particularly in emerging markets.

Previous Article
The Science of Obesity
The Science of Obesity

Available as of November 13, 2020

Next Article
Principles of ERAS & Why Now is the Time  to Implement ERAS to Address the Post-COVID Surgical Backlog
Principles of ERAS & Why Now is the Time to Implement ERAS to Address the Post-COVID Surgical Backlog

Available as of November 13, 2020